Free Trial
NASDAQ:ICU

SeaStar Medical 5/14/2024 Earnings Report

SeaStar Medical logo
$0.92 +0.07 (+8.29%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$0.91 0.00 (-0.23%)
As of 08/29/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SeaStar Medical EPS Results

Actual EPS
-$4.75
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

SeaStar Medical Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

SeaStar Medical Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

SeaStar Medical's Q3 2025 earnings is scheduled for Tuesday, November 11, 2025, with a conference call scheduled on Wednesday, November 12, 2025 at 3:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Conference Call Resources

SeaStar Medical Earnings Headlines

Take a look at this picture ...
A strange investment secret — discovered just a few short weeks before this image was taken — correctly predicted it all. Even crazier, this secret accurately called every major financial event in recent history … Now it's signaling something very scary is about to hit the market again …tc pixel
SeaStar Medical Resumes Stock Offering with New Price
See More SeaStar Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like SeaStar Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SeaStar Medical and other key companies, straight to your email.

About SeaStar Medical

SeaStar Medical (NASDAQ:ICU), a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.

View SeaStar Medical Profile

More Earnings Resources from MarketBeat